1. Metabolic Enzyme/Protease
  2. Isocitrate Dehydrogenase (IDH)
  3. Mutant IDH1-IN-1

Mutant IDH1-IN-1  (Synonyms: Agios 135)

Cat. No.: HY-12475 Purity: 99.43%
Handling Instructions Technical Support

Mutant IDH1-IN-1 (Agios 135) is a selective mutant IDH1 inhibitor with activity against both IDH1R132H and IDH1R132C. Mutant IDH1-IN-1 reduces the level of 2-hydroxyglutarate (2-HG), stabilizes mutant IDH1 protein, and restores blocked monocyte differentiation. Mutant IDH1-IN-1 can be used in tumor-related research.

For research use only. We do not sell to patients.

CAS No. : 1355326-21-4

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 2 publication(s) in Google Scholar

Top Publications Citing Use of Products

    Mutant IDH1-IN-1 purchased from MedChemExpress. Usage Cited in: Sci Rep. 2017 Oct 6;7(1):12758.  [Abstract]

    Represented western blot of an isothermal dose-response at melting temperature of 59°C demonstrating cellular mIDH1 enzyme thermal stabilization with mIDH1 inhibitors.

    View All Isocitrate Dehydrogenase (IDH) Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Mutant IDH1-IN-1 (Agios 135) is a selective mutant IDH1 inhibitor with activity against both IDH1R132H and IDH1R132C. Mutant IDH1-IN-1 reduces the level of 2-hydroxyglutarate (2-HG), stabilizes mutant IDH1 protein, and restores blocked monocyte differentiation. Mutant IDH1-IN-1 can be used in tumor-related research[1].

    IC50 & Target[1]

    IDH1

     

    In Vitro

    Mutant IDH1-IN-1 (30-50 min) potently inhibits purified recombinant IDH1R132H (with an IC50 of 0.38 µM) and IDH1R132C (with an IC50 of 0.09 µM), exhibits only weak activity against wild-type IDH1, and shows no activity against wild-type IDH2[1].
    Mutant IDH1-IN-1 (48 h) reduces 2-HG production in HT1080 (IDH1R132C), SNU1079 (IDH1R132C), RBE (IDH1R132S), JJ012 (IDH1R132G), U87 (IDH1R132H) and THP-1 (IDH1R132H) cells without significant cytotoxicity[1].
    Mutant IDH1-IN-1 (0.5 µM; 4 days) rescues doxycycline (HY-N0565)-induced monocytic differentiation of THP-1 (IDH1R132H) acute myeloid leukemia (AML) cells[1].
    Mutant IDH1-IN-1 (4 days) reduces 2-HG production in 3D tumor spheres of HT1080 (R132C), JJ012 (R132G), and U87 (R132H)[1].
    Mutant IDH1-IN-1 (compound 2) (30 min) potently inhibits the de novo reductive activity of the homodimeric IDH1R132H, with an IC50 of 0.042 μM[2].
    Mutant IDH1-IN-1 (30 min) potently inhibits the de novo reductive activity of the homodimeric IDH1R132C, with an IC50 of 0.004 μM[2].
    Mutant IDH1-IN-1 (30 min) inhibits the de novo reductive activity of the heterodimer IDH1R132H/WT, with an IC50 value of 0.080 μM[2].
    Mutant IDH1-IN-1 (30 min) inhibits the oxidative activity of the heterodimeric R132H/WT IDH1, with an IC50 of 0.143 μM[2].
    Mutant IDH1-IN-1 (30 min) inhibits the oxidative activity of the homodimeric WT/WT IDH1, with an IC50 value of 1.998 μM[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Differentiation Assay[1]

    Cell Line: THP-1 (R132H) AML cells engineered for doxycycline-inducible mIDH1 expression
    Concentration: 0.5 µM
    Incubation Time: 4 days
    Result: Increased the number of adherent differentiated THP-1 (R132H) cells compared to DMSO control, indicating rescue of the 2-HG-induced differentiation block.
    Molecular Weight

    498.59

    Formula

    C30H31FN4O2

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C(C(C1=C(C)C=CC=C1)N(C(CN2C=NC3=C2C=CC=C3)=O)C4=CC(F)=CC=C4)NC5CCCCC5

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 2 years
    -20°C 1 year
    Solvent & Solubility
    In Vitro: 

    DMSO : ≥ 45 mg/mL (90.25 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.0057 mL 10.0283 mL 20.0566 mL
    5 mM 0.4011 mL 2.0057 mL 4.0113 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    Purity & Documentation
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.0057 mL 10.0283 mL 20.0566 mL 50.1414 mL
    5 mM 0.4011 mL 2.0057 mL 4.0113 mL 10.0283 mL
    10 mM 0.2006 mL 1.0028 mL 2.0057 mL 5.0141 mL
    15 mM 0.1337 mL 0.6686 mL 1.3371 mL 3.3428 mL
    20 mM 0.1003 mL 0.5014 mL 1.0028 mL 2.5071 mL
    25 mM 0.0802 mL 0.4011 mL 0.8023 mL 2.0057 mL
    30 mM 0.0669 mL 0.3343 mL 0.6686 mL 1.6714 mL
    40 mM 0.0501 mL 0.2507 mL 0.5014 mL 1.2535 mL
    50 mM 0.0401 mL 0.2006 mL 0.4011 mL 1.0028 mL
    60 mM 0.0334 mL 0.1671 mL 0.3343 mL 0.8357 mL
    80 mM 0.0251 mL 0.1254 mL 0.2507 mL 0.6268 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Mutant IDH1-IN-1
    Cat. No.:
    HY-12475
    Quantity:
    MCE Japan Authorized Agent: